Taken together, these results suggest that HPS2 NLPHL show an increased number of Prf+CD8+ CTLs within the tumor nodules; this might reflect a defect in the release of this granules-associated protein by the CTL fraction. The gene discussed is CD8A; the disease is neoplasm.